Global Health Limited has informed the Exchange regarding 'Amendment in the Code of Conduct pursuant to the regulation 8 & 9 of SEBI (Prohibition of Insider Trading) Regulations 2015'.
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Global Health Limited (Medanta) has amended its Insider Trading Code of Conduct in line with SEBI's Prohibition of Insider Trading Regulations, 2015 (Regulations 8(1) and 9(1)). The revised code covers rules around the handling of Unpublished Price Sensitive Information (UPSI), trading windows, pre-clearance of trades by designated persons, and mandatory reporting of shareholdings. Designated persons must pre-clear any trade exceeding 1,000 shares or Rs. 10 lakh in value per quarter, and must report transactions within two trading days. The code also outlines procedures for investigating suspected leaks of UPSI, maintaining a structured digital database, and penalising violations including disgorgement of profits to SEBI. The amended policy is effective immediately and is available on the company's website.
This is a routine regulatory compliance update with no direct material impact on the company's financials or operations. It reinforces governance standards and may reassure investors about the company's insider trading controls, but is unlikely to move the stock price.